Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
214.50    0.00 (0.00%)
Bid:
211.00
Ask:
218.00
Spread: 7.00 (3.318%)
Market Cap: £146.53m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Quarterly Syndicate Mid-point Forecasts

26 Nov 2021 07:00

RNS Number : 6478T
Helios Underwriting Plc
26 November 2021
 

26 November 2021

 

Helios Underwriting plc

('Helios' or 'the Company')

 

Quarterly Syndicate Mid-point Forecasts

 

Helios, the unique investment vehicle which acquires and consolidates private underwriting capacity at Lloyd's, announces the current mid-point forecasts in respect of its portfolio of syndicate capacity for the 2019 and 2020 years of account based on 3rd quarter 2021 estimates.

 

Nigel Hanbury, Chief Executive, commented:

 

"As the only listed consolidator of private capital at Lloyd's, Helios continues to build a diversified and unique portfolio of insurance risk with top performing syndicates, having completed 21 acquisitions of Limited Liability Vehicles in the last three months, acquiring £22.7m of capacity on the 2021 underwriting year. Our strategy is bringing results, increasing our retained capacity to £81m for 2021 in a year where pricing, terms and conditions of the business underwriter have continued to improve.

We look forward to creating further shareholder value."

 

 

Year of Account

 

2019

2020

2021

 

£m

£m

£m

Capacity - Position as at 19th August 2021

 

 

 

Retained

31.3

30.9

58.6

Reinsured

39.0

49.1

51.6

 

70.3

80.0

110.2

 

 

 

 

Capacity Acquired since 19th August 2021

 

 

 

Retained

24.0

23.4

22.7

Reinsured

-

-

-

 

24.0

23.4

22.7

 

 

 

 

Total Capacity as at 25th November 2021

Retained

 

55.3

 

54.3

 

81.3

Reinsured

39.0

49.1

51.6

 

94.3

103.4

132.9

 

 

 

 

 

 

 

 

 

 

 

 

Mid-point forecast at 19th August 2021

0.01%

0.98%

 

Current mid-point forecast

0.65%

0.77%

 

 

 

 

 

Lloyd's Market Average

-3.50%

0.59%

 

Helios outperformance

4.15%

0.18%

 

 

Commentary

 

The mid-point forecasts have been calculated using the enlarged capacity including the capacity recently acquired. The midpoint estimate on a like for like basis using the capacity portfolio as at 19th August 2021 are as follows:

 

 

 

 

2019 YOA

2020 YOA

Mid-point forecast at 19th August 2021

0.01%

0.98%

Current mid-point forecast - "like for like portfolio"

1.40%

1.03%

 

The improvement in the results of the underlying portfolio before the effect of the capacity recently acquired continues to be in line with expectations. The 2019 current estimate shows a welcome increase over the estimate as at 19 August 2021. For 2020 underwriting year, there is a small improvement in the mid-point estimate in the underlying portfolio.

 

The outperformance of 4.15% of the portfolio against the average for the Lloyd's market for 2019 continues the trend of outperformance achieved over the last 6 years that averages over 4.7% during the period.

 

Notes

1) The table above shows the capacity as at 25th November 2021 splitting the capacity retained by Helios and the capacity that is ceded to quota share reinsurers. 

2) The mid-point forecasts for 2019 and 2020 years of account as of 3rd quarter 2021 have been aggregated at syndicate level from estimates supplied by Managing Agents.

3) The impact on Helios will be as follows:

a. The change in the mid-point estimates on the retained capacity over the year will be recognised in the Helios income statement in the year to 31st December 2021.

b. The overall change in the result will be recognised by Helios in cash at the close of the year of account.

 

For further information, please contact:

Helios Underwriting plc

Nigel Hanbury - Chief Executive +44 (0)7787 530 404 / nigel.hanbury@huwplc.com

Arthur Manners - Chief Financial Officer +44 (0)7754 965 917

 

Shore Capital

Robert Finlay +44 (0)20 7601 6100

David Coaten

 

Willis Re Securities (Financial Adviser)

Alastair Rodger +44 (0)20 3124 6033

 

Buchanan

Helen Tarbet / Henry Wilson / George Beale +44 (0)7872 604 453

+44 (0)20 7466 5111

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £133m of capacity for the 2021 account. The portfolio provides a good spread of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPGWWGUPGGQA
Date   Source Headline
5th Jun 20264:05 pmRNSGrant of LTIP Award
5th Jun 20267:00 amRNSGrant of LTIP Awards
1st Jun 20267:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSNotice of AGM
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSFinal Results for the year ended 31 December 2025
18th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTR-1 announcement
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
27th Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTR-1: Acquisition of Voting Rights
21st Apr 20267:00 amRNSChange of Nominated Adviser
20th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20265:17 pmRNSHolding(s) in Company
10th Apr 20267:00 amRNSDirector/PDMR Shareholding
9th Apr 20267:00 amRNSQuarterly Syndicate Mid-point Forecast update
20th Jan 20267:00 amRNS2026 YOA Portfolio Update
9th Jan 20267:00 amRNSAppointment of Chief Underwriting Officer
4th Dec 20255:42 pmRNSGrant of LTIP Awards
2nd Dec 20257:00 amRNSNet Asset Value(s)
13th Nov 20251:32 pmRNSDirector/PDMR Shareholding
13th Nov 20251:30 pmRNSDirector/PDMR Shareholding
7th Nov 202510:10 amRNSHolding(s) in Company
6th Nov 20251:51 pmRNSDirector/PDMR Shareholding
5th Nov 20255:48 pmRNSTR1 - Change in breakdown of voting rights
30th Oct 20257:00 amRNSResult of Tender Offer
24th Oct 202512:20 pmRNSResults of General Meeting
21st Oct 20257:01 amRNSDirector Appointments
21st Oct 20257:00 amRNSCapital Markets Day
29th Sep 20257:01 amRNSProposed Tender Offer and Notice of GM
29th Sep 20257:00 amRNSHalf Year Results
19th Sep 20257:00 amRNSAppointment of Chief Executive Officer
1st Sep 20253:37 pmRNSDirector/PDMR Shareholding
29th Aug 202512:52 pmRNSPDMR Dealing
28th Aug 20252:16 pmRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSQuarterly Syndicate Mid-point Forecasts
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 202512:12 pmRNSTR-1: Notification of major holdings
18th Jul 20257:00 amRNSResults of Scrip Dividend Election
9th Jul 20259:45 amRNSResults of Scrip Dividend Election
30th Jun 20255:40 pmRNSAppointment of Executive Director
30th Jun 202512:28 pmRNSResult of AGM
30th Jun 20257:00 amRNSChange of Nominated Adviser
20th Jun 20259:32 amRNSScrip Dividend Reference Price
9th Jun 20251:15 pmRNSLTIP Exercise and Total Voting Rights Update
9th Jun 20251:15 pmRNSGrant of LTIP Awards
2nd Jun 20257:00 amRNSPosting of Annual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.